{"id":"W2949991172","doi":"10.1097/01.hs9.0000567032.31064.27","title":"PB2137 SUBGROUP ANALYSIS OF PATIENTS FROM CANADA AND THE UNITED STATES IN THE PHASE 3 FIRST TRIAL IN TRANSPLANT‐INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Leukemia & Lymphoma Society of Canada; McGill University Health Centre; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Multiple myeloma; Internal medicine; Melphalan; Prednisone; Progression-free survival; Surgery; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002243411,0.0001678758,0.0005424165,0.0001542465,0.00004495701,0.0000174553,0.0001498504,0.00005856633,0.0003225847],"category_scores_gemma":[0.00018233,0.00008995157,0.00009471841,0.001158378,0.00007454893,0.0000456998,0.00002155382,0.0001826327,0.000003155508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000085199,"about_ca_system_score_gemma":0.0001328699,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8897249,"about_ca_topic_score_gemma":0.9435307,"domain_scores_codex":[0.9983712,0.0002060936,0.0003957293,0.0002531295,0.0004794089,0.0002944318],"domain_scores_gemma":[0.9975336,0.001854281,0.00009154897,0.000366201,0.00005836059,0.00009607364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04433958,0.0007953633,0.9504197,0.00005172012,0.0005444105,0.00013432,0.00237246,0.000229857,0.00001541027,0.000006638923,0.0002164975,0.0008739913],"study_design_scores_gemma":[0.2478879,0.0003054591,0.7334192,0.00007925761,0.0003406222,4.707681e-7,0.001164638,0.01610109,0.0001521176,0.00001412601,0.000442378,0.00009271876],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970607,0.0002655158,0.000004141833,0.0004056229,0.00003970854,0.001615951,0.0005103159,0.00000602503,0.00009198168],"genre_scores_gemma":[0.9973364,0.0002612117,0.00003068178,0.0001837904,0.00001792809,0.00009467996,0.00201315,0.00001205364,0.00005005604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2170005,"threshold_uncertainty_score":0.3668118,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01440336199869468,"score_gpt":0.2654622143583468,"score_spread":0.2510588523596521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}